Haoxi Health Technology Ltd (HAO) stock
HAONasdaqServices-Advertising AgenciesFiscal year ends June 30
$1.81−0.05 (-2.69%)
Close on Nov 12, 2026Market cap $201.14KP/E –Yield –
Haoxi Health Technology r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2026 it was $104.36K, up 31.2% from the year before. The highest annual figure on record is $104.36K in fiscal 2026.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $104.36K | +31.2% |
| FY2025 | Jun 30, 2025 | $79.54K | -0.6% |
| FY2024 | Jun 30, 2024 | $79.99K | +37.5% |
| FY2023 | Jun 30, 2023 | $58.16K | -43.3% |
| FY2022 | Jun 30, 2022 | $102.52K | – |
See a number that looks wrong?